Anuradha Acharya is the CEO, Mapmygenome. She is currently serving as a governing board member at Council for Scientific and Industrial Research (CSIR). While speaking with The wp Journal, she expressed the need to increase awareness about health and medical issues amongst employees. Taking into consideration the health scenario of the nation, which carries 20% of the world’s burden of TB patients; she suggests how corporate funding for low cost affordable medicines can be a good start. Anuradha has also received the ” Young Global Leader” award by the World Economic Forum.
When you work for the larger good, you’re doing good for yourself too: Anuradha Acharya
Related Articles
Mounjaro Becomes The World’s Best-Selling Drug, Surpasses Keytruda
The diabetes and obesity medication Mounjaro, produced by US pharmaceutical company Eli Lilly, has now surpassed Merck's cancer treatment Keytruda to become the leading-selling...
India Launches Swasth Bharat Portal to Integrate Health Systems
The Swasth Bharat Portal has been launched as a significant advancement in the digital transformation of healthcare in India. The initiative was introduced by...
Daily Consumption of Lemon Honey Water May Have Various Benefits
Beginning the day with warm lemon honey water is a common wellness practice among many individuals. This drink is believed to enhance hydration levels...